CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +22,711 | $8.46 | $192K | 336,475 |
| 2026-07-15 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −105,762 | $22.59 | $2.4M | 230,713 |
| 2026-07-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −59,374 | 0 | ||
| 2026-07-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −23,677 | 132,246 | ||
| 2026-07-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −22,711 | 37,511 | ||
| 2026-07-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −239,351 | $21.74 | $5.2M | 1,166,547 |
| 2026-07-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −146,889 | $22.45 | $3.3M | 1,019,658 |
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +12,626 | $7.80 | $98K | 250,314 |
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +12,600 | $12.14 | $153K | 262,914 |
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +12,637 | $8.46 | $107K | 275,551 |
| 2026-07-02 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −44,838 | $22.59 | $1.0M | 230,713 |
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,626 | 59,374 | ||
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,600 | 155,923 | ||
| 2026-07-02 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,637 | 60,222 | ||
| 2026-07-01 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −487 | $22.00 | $11K | 406,288 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 254,434 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +3,300 | $12.14 | $40K | 257,734 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +12,206 | $8.46 | $103K | 269,940 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +4,688 | $3.99 | $19K | 274,628 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +14,064 | $8.12 | $114K | 288,692 |
Page 9 of 119 · 2,375 trades